BACKGROUND: Exercise stress testing has diagnostic value in long QT syndrome (LQTS). In adults, the transition from supine to standing is used to diagnose LQTS. This relationship is not well understood in younger patients. There are innate difficulties in measuring the QT intervals during exercise, and autonomic changes that occur in adolescence may lead to over diagnosis. We compared QT changes during the exercise test in patients with LQTS to normal subjects and those with a borderline evaluation for LQTS. METHODS: In this retrospective review we measured QTc in the supine position, standing, at two minutes of exercise, and in one minute and three minutes into recovery in a group of clinically diagnosed LQTS (n¼10), borderline QT (n¼10) and healthy controls (n¼25). Borderline patients were those who had no evidence of LQTS at baseline, negative family history, no pathogenic variants and had abnormal exercise testing. No patient was on medication at the time of testing. The QTc interval was calculated using the Bazett formula.
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A one-way ANOVA was performed and a Tukey HSD post-hoc test was used to determine differences between groups. A p-value of 0.05 was considered statistically significant. RESULTS: In the supine position, healthy controls had a significantly shorter QTc than both the borderline QT (p¼0.041) and the confirmed LQTS (p0.001) groups. This difference remained upon standing (p¼0.005 and p¼0.001). There was no difference between the groups at two minutes of exercise. In recovery, the QTc was only different between controls and the confirmed LQTS group, but not the borderline QT group, at both one minute (p¼0.001) and three minutes of recovery (p¼0.003). CONCLUSION: The exercise stress test must be interpreted cautiously in the context of the adolescent patient and the stand test may not be useful in these patients. Careful measurement of the QT is critical. Despite the proven benefit of oral anticoagulation (OAC) in reducing the risk of stroke among atrial fibrillation (AF) patients, there is lingering concern that persistence with these life-saving medications is suboptimal in routine clinical practice. From a prospective registry, we sought to examine: (i) the one-year persistence rates to warfarin and non-vitamin K oral anticoagulants (NOAC) and (ii) factors associated with OAC persistence. METHODS AND RESULTS: We enrolled 2,498 AF patients from 132 community-based sites in Canada (November 2013 to March 2016) in a prospective registry. Use of OAC at one year was ascertained by telephone follow-up. Multivariable logistic regression was performed to examine for factors associated with continued OAC use (vs. non-use) at one-year. Among patients who remained treated with OAC at one-year, a multivariable logistic regression was performed to examine for factors associated with use of the same OAC agent vs. being switched to another OAC agent. Among the 2,010 patients treated with OAC at baseline, one-year data on OAC use were obtained for 1,387 (69%) patients. In this cohort, 124 patients (8.9%) were no longer treated with OAC at one-year. The rates of OAC discontinuation of warfarin-and NOAC-treated patients were 5.1% and 10.5%, respectively (P<0.05). The distribution of OAC use at one-year, stratified by baseline OAC use, was shown in the figure. On multivariable regression analysis, use of NOAC and concomitant use of antiplatelet agents were associated with increased likelihood of OAC discontinuation at one-year (odds ratio (OR) 2.22, 95% CI 1.35-3.70 and OR 2.50, 95% CI 1.54-4.00). Among patients who remained treated with OAC at one-year, the odds of staying on the same OAC agent were higher for patients treated with factor Xa inhibitors when compared to those treated with warfarin at baseline (OR 1.64, 95% CI 1.05-2.54 (rivaroxaban vs. warfarin) and OR 5.26, 95% CI 2.22-12.5 (apixaban vs. warfarin)). Similar results were obtained when our analysis was restricted to patients treated with the same OAC for >90 days prior to their baseline visit.
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